FDA
- Status: approved
OPTI-FREE® RepleniSH® (OPTI-FREE® RepleniSH®) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Massachusetts Eye and Ear Infirmary is the originator. The local marketing authorisation holder may differ — check the official source linked above.